Literature DB >> 28671088

Correlation study of cough variant asthma and mycoplasma pneumonia infection in children.

Wen Li1, Cunfang Ban2, Junxia Zhang2, Yingying Hu2, Bingjuan Han3, Bingchao Han4.   

Abstract

Cough variant asthma (CVA), as one of bronchitis diseases, features with repeated cough. In clinics, CAV does not show significant abnormal signs, therefore antibiotic therapy can hardly achieve satisfactory treatment effect. With the development of scientific technologies, the correlation between mycoplasma pneumoniae infection and CVA has become a hot research topic in clinics. In clinics, mycoplasma pneumoniae is extensively regarded as major cause for CVA, with complex pathogenic mechanism. The symptoms of CVA is characterized by chronic non abnormal inflammation, normally accompanied with bronchospasm and intestinal infection. Clinical practices show that about 6% of CVA children mainly show continuous cough till midnight during onset period, which is easily to misdiagnosed as bronchitis. Mycoplasma pneumoniae infection is a common disease threatening Children's health in China. With the annual increase of incidence of infantile pneumonia in China, mycoplasma pneumoniae infection has become a major reason leading to the death of child in China. More such mycoplasma pneumoniae infection is a sporadic disease spreading in a small range, and can onset in four seasons, making great impact on living quality and health of children. On this basis, this paper analyzes the correlation between Children's CVA and mycoplasma pneumoniae infection, in the hope of providing valuable reference for clinical treatment.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28671088

Source DB:  PubMed          Journal:  Pak J Pharm Sci        ISSN: 1011-601X            Impact factor:   0.684


  4 in total

1.  The effect of montelukast sodium plus budesonide on the clinical efficacy, inflammation, and pulmonary function in children with cough variant asthma.

Authors:  Lijuan Chen; Manqin Huang; Nanli Xie
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

2.  LncRNA NEAT1 Regulates Infantile Pneumonia by Sponging miR-146b.

Authors:  Jingjing Cui; Jian Wang; Yeke Lv; Dong Xu
Journal:  Mol Biotechnol       Date:  2021-05-12       Impact factor: 2.695

3.  Montelukast and budesonide combination for children with chronic cough-variant asthma.

Authors:  Xiu-Ping Wang; Lin-Dong Yang; Jin-Fang Zhou
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

4.  Evaluation of efficiency and safety of combined montelukast sodium and budesonide in children with cough variant asthma: A protocol for systematic review and meta-analysis.

Authors:  Qiongyao Tang; Huizhen Lei; Jinbing You; Jiangjiang Wang; Junyi Cao
Journal:  Medicine (Baltimore)       Date:  2021-06-25       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.